What happens when you take sertraline with St. John's wort?
Sertraline is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for depression, anxiety disorders, OCD, PTSD, and panic disorder. It works by blocking the serotonin transporter in the brain, leaving more serotonin available in the synapse to bind to receptors. St. John's wort (Hypericum perforatum) is an over-the-counter botanical that has been used for mild to moderate depression. Its active constituents - hyperforin and hypericin in particular - inhibit the reuptake of serotonin, norepinephrine, and dopamine, with hyperforin acting on the same serotonin transporter that sertraline targets.
When the two are taken together, the additive blockade of serotonin reuptake can push synaptic serotonin to dangerous levels. This is the mechanism behind serotonin syndrome, a clinical triad of altered mental status (agitation, confusion, hallucination), autonomic hyperactivity (tachycardia, hypertension, fever, sweating, dilated pupils, diarrhea), and neuromuscular abnormalities (tremor, clonus, hyperreflexia, rigidity). Mild forms feel like a hot, anxious, twitchy flu. Severe forms can progress to seizures, rhabdomyolysis, disseminated intravascular coagulation, and death.
There is a second, opposite problem in the same combination. St. John's wort is one of the most potent botanical inducers of the cytochrome P450 enzyme system, especially CYP3A4, CYP2C19, and CYP2C9. Sertraline is partially metabolized by CYP2C19 and CYP3A4, so chronic St. John's wort use can speed up sertraline clearance and lower its blood levels - sometimes enough to trigger a return of depressive symptoms even though the patient is technically still on their medication.
Why is this important?
Serotonin syndrome is not a rare theoretical risk. Published case reports and pharmacovigilance reviews describe patients developing classic serotonin toxicity within days of adding St. John's wort to an SSRI, including sertraline. The 2025 European Psychiatry review specifically names sertraline and paroxetine as the SSRIs most commonly implicated in St. John's wort interactions. National medicines authorities, including Medsafe (New Zealand) and the U.S. National Center for Complementary and Integrative Health (NCCIH), state that the combination is not recommended.
The problem is compounded by perception. Patients often consider St. John's wort "natural" and may not mention it to their prescriber or pharmacist, so the interaction never makes it onto the medication reconciliation list. Some products are not even labeled clearly - it has been found in teas, multi-herb "mood" blends, sleep formulas, and women's wellness supplements. A patient stable on sertraline can therefore introduce significant serotonergic load without realizing it.
The induction effect is also clinically meaningful. CYP enzyme induction takes about a week to ramp up and can persist for one to two weeks after stopping St. John's wort. That means a patient who quits the supplement abruptly may have a rebound rise in sertraline levels (worsening serotonin syndrome risk) and then a slow normalization period during which dosing decisions get complicated.
What should you do?
If you are currently prescribed sertraline, do not start St. John's wort, and stop any current St. John's wort use only after speaking with your prescriber - they may want to monitor for both a possible rise in sertraline level and any change in mood. If you are taking the combination right now and feel anxious, sweaty, shaky, feverish, or your heart is racing, treat that as an emergency and go to an emergency department. Bring the supplement bottle so clinicians can see the dose and brand.
If you and your doctor decide to switch from one to the other, plan a washout. A typical approach is to stop St. John's wort and wait one to two weeks before starting sertraline at a low dose, or to taper sertraline, allow approximately a week of clearance, and then consider St. John's wort - though most psychiatrists prefer a different evidence-based medication over restarting a botanical with such an unpredictable enzyme-induction profile.
Always disclose every supplement, tea, and herbal product to your prescribing clinician and pharmacist, including products marketed for sleep, mood, or "calm." If you fill prescriptions at multiple pharmacies, keep one master list. Pharmacists can flag the interaction at the point of dispense if they know what is on board.
Which specific products are affected?
This warning applies to all branded and generic sertraline products, including Zoloft, Lustral, and authorized generics. On the supplement side, it applies to any product containing Hypericum perforatum, including standardized extracts (often labeled 0.3% hypericin or 3-5% hyperforin), teas, tinctures, and combination products. Watch for combination herbal supplements branded as "mood support," "happy tea," "calm," "emotional balance," or "5-HTP plus," which sometimes contain hidden St. John's wort. Also watch for products imported under regional names like Hypericum, Johanniskraut (German), millepertuis (French), or hierba de San Juan (Spanish).
Be aware that other serotonergic agents stack on top of this risk: tramadol, triptans (sumatriptan, rizatriptan), MAO inhibitors, linezolid, MDMA, dextromethorphan, lithium, and other SSRIs/SNRIs. The St. John's wort plus sertraline pairing is particularly hazardous because both are taken chronically and at home, without clinical monitoring.
The bottom line
Sertraline plus St. John's wort is a high-risk combination that can cause serotonin syndrome and, paradoxically, also reduce sertraline efficacy through CYP enzyme induction. Major drug-interaction databases and the U.S. NCCIH classify the pair as one to avoid. If you are on sertraline, treat St. John's wort as off-limits unless and until your prescriber explicitly tells you otherwise, and disclose every herbal product you take.